ArticleBritish journal of cancer2019

Synergistic antitumour activity of HDAC inhibitor SAHA and EGFR inhibitor gefitinib in head and neck cancer: a key role for ΔNp63α.

Simona Citro et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.